NDZEMBANTEH ABOUBAKARY NULAMBEH – Pharmacogenomics – Best Researcher Award

Posted on by sciencefather

NDZEMBANTEH ABOUBAKARY NULAMBEH - Pharmacogenomics - Best Researcher Award

The University of Bamenda - Cameroon

INTRODUCTION

NDZEMBANTEH ABOUBAKARY NULAMBEH is a seasoned economist with a strong academic and professional background spanning over eight years. Based in Buea and Douala, Cameroon, he has a proven track record in teaching, research, and consultancy in economics. With expertise in quantitative and qualitative research methods, he has contributed significantly to the fields of sustainable finance, renewable energy, poverty and inequality, climate neutrality, and Islamic banking and finance. His academic journey is marked by achievements from prestigious institutions in Cameroon, Malaysia, and Turkey.

ACADEMIC AND PROFESSIONAL CAREER

Dr. Nulambeh earned his PhD in International Economics from Bursa Uludag University, Turkey, where he conducted groundbreaking research on sustainable development. He also holds a Master of Science in Economics from the International Islamic University of Malaysia and a Bachelor of Science in Economics from the University of Yaounde 2, Soa, Cameroon. He has served as an Assistant Lecturer at the Higher Institute of Management Studies and ISTGAC Maaron University Institute in Cameroon since 2021. Previously, he was an Assistant Professor at UNITAR International University in Malaysia, where he excelled in curriculum development and teaching.

RESEARCH CONTRIBUTIONS AND PUBLICATIONS

Dr. Nulambeh's research portfolio includes influential publications that explore the intersections of finance, economics, and environmental sustainability. His works address critical issues such as the energy-environment growth nexus, financial development, and the environmental Kuznets curve in African contexts. Notable publications include studies on the role of human capital and innovation in economic growth and the impact of foreign direct investment on trade openness. His research is featured in high-impact journals, reflecting his dedication to advancing economic knowledge.

CONFERENCES AND SEMINARS

Dr. Nulambeh actively participates in international conferences and seminars, presenting his research to global audiences. He has delivered insights on environmental quality, sustainable finance, and inclusive growth at events such as the Istanbul Finance Conference and Uludag University’s International Conference of Economics and Business. These engagements demonstrate his commitment to fostering academic discourse and influencing policy frameworks.

SKILLS AND TEACHING EXPERTISE

Dr. Nulambeh's extensive teaching experience spans applied econometrics, statistics, mathematical economics, and Islamic finance. His mastery of tools like SPSS, Eviews, Stata, and R complements his pedagogical expertise. Known for his superb classroom organization and mentorship skills, he has been instrumental in shaping the academic and professional trajectories of his students.

CONCLUSION

Dr. Nulambeh is a forward-thinking economist dedicated to addressing contemporary global challenges through innovative research and education. His focus on sustainable finance, green growth, and climate neutrality underscores his commitment to a future of inclusive and equitable development. He continues to inspire through his teaching, publications, and contributions to economic research and policy-making.

NOTABLE PUBLICATION

Foreign direct investment, trade openness and economic growth: A panel data analysis for sub-Saharan Africa 2018 (24)

The impact of human capital and innovation output on economic growth: comparative analysis of Malaysia and Turkey 2020 (15)

Exports, Imports, Exchange rates, Gross domestic investment, and Growth: Empirical Evidence from Cameroon 2016 (15)\

Exploring the energy-environment growth nexus in francophone Africa in presence of institutions 2022 (2)

Factors Contributing to the Acceptance of Verify Halal App Among the Malaysian Muslim Consumers 2024

Taghrid Alomar – Herbal Medicine and Nutraceuticals – Best Researcher Award

Posted on by sciencefather

Taghrid Alomar - Herbal Medicine and Nutraceuticals - Best Researcher Award

Princess Nourah University - Saudi Arabia

Introduction

Taghrid Alomar is an esteemed academic and researcher specializing in analytical chemistry, with a particular focus on the analysis of pharmaceutical compounds using enhanced Raman scattering and nanotechnology. With a robust academic background and a wealth of experience in both research and teaching, Dr. Alomar has made significant contributions to the field of modern analytical techniques, particularly in pharmaceutical analysis. Her work has been published in several prestigious international journals, further solidifying her standing in the scientific community.

Enhanced Raman Scattering in Pharmaceutical Analysis

Dr. Alomar has conducted pioneering research in the application of enhanced Raman scattering (ERS) for the analysis of pharmaceutical compounds. Her studies have focused on improving the sensitivity and accuracy of Raman techniques, providing novel methods for drug characterization and quality control. This research is crucial in the development of more efficient and precise analytical tools for the pharmaceutical industry.

Nanotechnology in Analytical Chemistry

A significant area of Dr. Alomar's research involves the use of nanotechnology to enhance the capabilities of traditional analytical methods. She explores the integration of nanoparticles with analytical chemistry techniques to improve detection limits, speed, and the ability to analyze complex biological samples. This work holds immense potential in drug testing and diagnostic applications.

Chemical Analysis Devices for Pharmaceutical Compounds

Dr. Alomar has contributed to the development and optimization of chemical analysis devices that are specifically tailored for pharmaceutical analysis. These devices, designed to meet the growing demands of modern chemistry and pharmacology, enable more precise, efficient, and cost-effective analysis of pharmaceutical compounds.

Separation of Chemical Compounds from Natural Materials

Her earlier research focused on the separation and analysis of chemical compounds from natural materials. Dr. Alomar's work in this area has advanced techniques for isolating bioactive compounds from plants and other natural sources, opening the door for the development of new, naturally-derived pharmaceuticals.

Academic Contributions and Educational Initiatives

In addition to her research, Dr. Alomar has played a key role in advancing chemistry education. She has held various academic leadership positions, including Coordinator of Student Affairs and Vice-Dean of Student Affairs, where she contributed to the development of educational programs and the enhancement of student experiences in the preparatory years of health colleges.

Conclusion

Taghrid Alomar’s work exemplifies a commitment to advancing the field of analytical chemistry and pharmaceutical sciences. Through her research in enhanced Raman scattering, nanotechnology, and the development of analytical devices, she continues to make impactful contributions to the medical and scientific communities. With her extensive teaching experience and leadership roles, Dr. Alomar has also shaped the next generation of chemists and researchers, further cementing her influence in the field.

NOTABLE PUBLICATION

High-conductivity nickel shells encapsulated wood-derived porous carbon for improved electromagnetic interference shielding 2023 (110)

Remediation of pesticides using TiO2 based photocatalytic strategies: A review 2022 (91)

Green route synthesis and characterization techniques of silver nanoparticles and their biological adeptness 2022 (91)

An eco-friendly plant-mediated synthesis of silver nanoparticles: Characterization, pharmaceutical and biomedical applications 2020 (86)

Biogenic synthesis of silver nanoparticles using Trigonella foenum-graecum seed extract: Characterization, photocatalytic and antibacterial activities 2021 (71)

Katiane – Medicinal Chemistry – Best Researcher Award

Posted on by sciencefather

Katiane - Medicinal Chemistry - Best Researcher Award

UFPE - Brazil

Introduction

Katiane Cruz Magalhães Xavier is a dedicated researcher in the field of chemistry, with a particular focus on inorganic chemistry, materials science, and environmental applications. Her academic journey has led her to explore a wide range of topics, including the activation of clays for industrial applications, the use of natural materials for oil clarification, and the development of sustainable solutions for biotechnological purposes. Currently pursuing a PhD in Chemistry at the Federal University of Pernambuco (UFPE), her work continues to push the boundaries of chemical research with an emphasis on both academic and practical outcomes.

Inorganic Chemistry and Clay Activation

Katiane's research on the thermal activation of palygorskite, a natural clay mineral, has contributed significantly to the field of inorganic chemistry. Her work on using thermally activated palygorskite to clarify soybean oil, published in Applied Clay Science (2016), has garnered attention for its potential to improve industrial processes related to oil purification. This study not only highlights the utility of clay materials but also presents an environmentally friendly alternative to conventional oil clarification methods.

Materials Science and Surface Modifications

Katiane has also made substantial contributions to materials science, particularly in understanding the effects of acid treatment on clay minerals. Her collaborative research, featured in Materials Research (2014), examined how acid treatment alters the surface area, morphology, and chemical composition of palygorskite, paving the way for more efficient applications of clays in various industries. These insights are crucial for the development of enhanced materials that are both functional and sustainable.

Environmental and Biotechnological Applications

As part of her doctoral research at UFPE, Katiane is exploring the use of macroalgae from the Pernambuco coast. Her project, titled Macroalgae from the Pernambuco Coast: From the Use of Crude Extracts to Electrospun Films for Biotechnological Applications, focuses on harnessing the biotechnological potential of marine resources. By creating electrospun films from macroalgae extracts, she aims to develop innovative materials for use in various biotechnological fields, including medicine, environmental science, and materials engineering.

Oil Purification and Environmental Sustainability

Katiane's work on oil clarification extends beyond traditional chemical methods and emphasizes environmentally sustainable approaches. Her research into using thermally activated clays, particularly in the context of soybean oil purification, offers a green alternative to chemical treatments. This work aligns with global trends in minimizing the environmental impact of industrial processes and contributes to the development of cleaner technologies in the food and pharmaceutical industries.

Interdisciplinary Research in Chemistry

Katiane's research is rooted in the intersection of several disciplines, including inorganic chemistry, materials science, and environmental chemistry. Her ability to bridge these areas allows for a holistic approach to problem-solving, addressing both practical and theoretical challenges. This interdisciplinary methodology has equipped her with the skills to develop solutions that are not only scientifically sound but also applicable in real-world scenarios.

Conclusion

Katiane Cruz Magalhães Xavier’s academic and research career has been defined by her commitment to advancing the fields of inorganic chemistry, materials science, and biotechnological applications. Through her innovative work on clay activation, oil clarification, and macroalgae-based materials, she continues to contribute valuable knowledge that could have far-reaching implications in both industrial and environmental sectors. As a doctoral candidate at UFPE, her research promises to further enhance our understanding of natural materials and their potential for sustainable development.

NOTABLE PUBLICATION

Thermally activated palygorskites as agents to clarify soybean oil

Effects of acid treatment on the clay palygorskite: XRD, surface area, morphological and chemical composition

Benjamin Haibe Kains – Pharmacoeconomics – Best Researcher Award

Posted on by sciencefather

Benjamin Haibe Kains - Pharmacoeconomics - Best Researcher Award

University Health Network - Canada

Introduction

Dr. Benjamin Haibe-Kains is a renowned researcher and scientist specializing in the fields of pharmacogenomics, radiomics, research reproducibility, and software development. He is a leader in computational biology and data science, with a specific focus on the application of machine learning algorithms and genomic data to revolutionize cancer treatment and clinical decision-making. Through his interdisciplinary approach, Dr. Haibe-Kains has made significant contributions to biomarker discovery, drug repurposing, and the development of artificial intelligence (AI) tools that enhance clinical practices.

Pharmacogenomics

Dr. Haibe-Kains' research in pharmacogenomics focuses on understanding the genetic basis of drug responses. His lab investigates the interplay between genomic information and pharmacological data to predict cancer progression and identify optimal treatment options. His work leverages preclinical and clinical data to advance drug repurposing efforts, helping to find new applications for existing drugs in the treatment of cancer.

Radiomics

In the realm of radiomics, Dr. Haibe-Kains is developing cutting-edge machine learning algorithms that extract high-dimensional features from medical imaging data. His team aims to improve diagnostic accuracy, predict cancer progression, and refine clinical decision-making. The creation of prognostic and predictive radiomic models is central to his work, potentially transforming the way clinicians use imaging in the treatment of cancer.

Research Reproducibility and Open Science

A passionate advocate for research reproducibility and transparency, Dr. Haibe-Kains emphasizes the importance of open science principles. His lab is working towards improving the transparency of AI research, particularly in the use of multimodal data for biomarker discovery. By developing best practices and utilizing cloud-based technologies, his team is advancing reproducibility in AI research, ensuring that research findings are accessible and replicable across the scientific community.

Software Development for Translational Research

In addition to his scientific research, Dr. Haibe-Kains is dedicated to translating his findings into practical tools for the research and clinical communities. His lab develops software packages, web applications, and databases that empower researchers and clinicians to conduct pharmacogenomic and radiomic analyses. These tools are designed to facilitate the analysis of both preclinical and clinical data, ultimately improving the treatment and management of cancer.

Honours and Career Achievements

Dr. Haibe-Kains has earned numerous accolades throughout his career, including the 2022 New Scholar award from the Royal Society of Canada, the 2021 MAQC Society Award, and the 2020 Canadian Cancer Society’s Bernard and Francine Dorval Prize. His achievements also include prestigious research grants, such as the Canadian Research Chair Tier 2 in Computational Pharmacogenomics and the Early Career Researcher Program award from the Canadian Institutes of Health Research.

Conclusion

Dr. Benjamin Haibe-Kains is at the forefront of integrating computational biology, AI, and pharmacogenomics to drive innovation in cancer treatment. Through his research, software development, and commitment to open science, he continues to shape the future of personalized medicine and improve the quality of healthcare. His work exemplifies the power of multidisciplinary collaboration and technological advancement in transforming clinical outcomes and advancing the field of cancer research.

NOTABLE PUBLICATION

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach 2014 (5160)

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis 2006 (2363)

Similarity network fusion for aggregating data types on a genomic scale 2014 (1921)

CD4+ follicular helper T cell infiltration predicts breast cancer survival 2013 (1103)

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures 2008 (1057)

Zhao-Jie Wang – Medicinal Chemistry – Best Researcher Award

Posted on by sciencefather

Zhao-Jie Wang - Medicinal Chemistry - Best Researcher Award

Yunnan Normal University - China

Introduction

Dr. Zhao-Jie Wang is an eminent researcher in the field of natural products, medicinal chemistry, and pharmacology. With an extensive portfolio of over 33 SCI-indexed publications, Dr. Wang has made substantial contributions to understanding antimicrobial compounds, drug development, and therapeutic strategies against multidrug-resistant pathogens. His research bridges phytochemistry and pharmacology, offering innovative solutions to pressing challenges in infectious diseases and antimicrobial resistance.

Antimicrobial Natural Products

Dr. Wang has extensively studied bioactive compounds derived from plants and fungi to combat multidrug-resistant bacteria and fungi. His work, featured in leading journals like Journal of Ethnopharmacology and Food Chemistry: X, provides a comprehensive analysis of plant-based antimicrobial agents, their chemical compositions, and mechanisms of action. His studies on Zanthoxylum species and Sigesbeckia orientalis are pivotal in discovering new therapeutic agents.

Multidrug-Resistant Bacterial Infections

A significant aspect of Dr. Wang's research focuses on developing novel strategies to address multidrug-resistant (MDR) bacterial infections. His study on light-controllable chitosan micelles for bacterial biofilm treatment, published in Carbohydrate Polymers (IF=11.2), exemplifies his innovative approach. This research provides a promising avenue for combating MDR bacteria using advanced nanotechnology.

Phytochemical Analysis and Bioactivity

Dr. Wang has explored the phytochemistry of various herbs and their bioactivity against pathogens. His work includes detailed characterization of chemical constituents using LC-MS and their evaluation for antibacterial, antifungal, and nematicidal activities. Studies published in Journal of Agricultural and Food Chemistry and Heliyon highlight his expertise in bridging traditional herbal medicine with modern pharmacology.

Therapeutic Strategies for Infectious Diseases

With a focus on infectious diseases, Dr. Wang has proposed innovative therapeutic strategies to combat intracellular MDR bacteria. His study published in the Journal of Controlled Release (IF=10.8) offers groundbreaking insights into targeted drug delivery systems and their potential to improve therapeutic efficacy against challenging infections.

Bioactivity-Driven Drug Development

Dr. Wang’s research on bioactivity-driven isolation and characterization of antifungal and antibacterial compounds has significantly contributed to drug development. Studies on compounds such as diterpenoids, ent-kaurane diterpenes, and formononetin derivatives underscore his efforts in identifying potential therapeutic agents for osteoclast regulation and bacterial resistance management.

Conclusion

Dr. Zhao-Jie Wang's diverse and impactful research continues to advance the understanding of natural products, antimicrobial pharmacology, and innovative therapeutic approaches. His multidisciplinary expertise and commitment to addressing global health challenges have established him as a leading figure in the field of pharmacology and medicinal chemistry. Through his work, Dr. Wang aims to contribute to the development of safer and more effective treatments for drug-resistant pathogens, ensuring a brighter future for global healthcare.

NOTABLE PUBLICATION

Siegesoxylipin A‒J, previously undescribed phyto-oxylipins inhibition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci from Sigesbeckia orientalis

Diterpenoids of Caryopteris trichosphaera W. W. Sm. inhibiting MRSA and VRE in vitro and in vivo.

Oleanolic acid derivatives against drug-resistant bacteria and fungi by multi-targets to avoid drug resistance

Phytocannabinoid-like meroterpenoids from twigs and leaves of Rhododendron spinuliferum

New resorcylic acid derivatives of Lysimachia tengyuehensis against MRSA and VRE by interfering with bacterial metabolic imbalance

Rahul K. Reddy – Pharmacology – Excellence in Research

Posted on by sciencefather

Rahul K. Reddy - Pharmacology - Excellence in Research

Lautoka Hospital - Fiji

Introduction

Rahul K. Reddy is an accomplished researcher and medical professional specializing in urology, surgery, and trauma care. With a focus on advancing medical understanding and clinical outcomes in challenging cases, Dr. Reddy has contributed significantly to the fields of laparoscopic surgery, burn care, and acute surgical conditions. His work is characterized by its depth of clinical insight and dedication to improving patient outcomes in diverse healthcare settings, particularly in Fiji.

Laparoscopic Surgery in Urology

Dr. Reddy's pioneering work in the laparoscopic excision of seminal vesicle cystadenoma underscores his expertise in minimally invasive surgical techniques. Published in Urology Case Reports (2019), this study has provided valuable insights into rare urological conditions, offering innovative approaches to their management.

Burn Injury Characteristics and Outcomes

In collaboration with a multidisciplinary team, Dr. Reddy conducted an in-depth analysis of burn injury patterns and treatment outcomes at Lautoka Hospital. His findings, featured in Burns Open (2024), have contributed to the optimization of burn care protocols in resource-limited settings, enhancing recovery rates and patient care quality.

Acute Appendicitis Management

Through an observational retrospective study on acute appendicitis at Lautoka Aspen Hospital, Dr. Reddy explored the clinical characteristics and outcomes over a one-year period (2022–2023). Published in World Journal of Surgical Research (2024), this research offers evidence-based recommendations for improving appendicitis management in Pacific Island healthcare systems.

Rare Tumors and Pathologies

Dr. Reddy has also delved into the study of rare pathologies, such as primary epithelioid hemangioendothelioma of the kidney pelvis. His case report, published in the American Journal of Surgery and Clinical Case Reports (2020), adds to the limited literature on this rare tumor type, emphasizing the importance of early diagnosis and tailored surgical interventions.

Trauma and Emergency Medicine

With a holistic approach to trauma care, Dr. Reddy's research addresses the critical needs of patients in emergency settings. His work highlights the significance of multidisciplinary collaboration and protocol-driven management in achieving favorable outcomes for complex trauma cases.

Conclusion

Rahul K. Reddy’s extensive research portfolio reflects his unwavering commitment to advancing medical science and improving patient care. By addressing diverse challenges in urology, surgery, and trauma care, Dr. Reddy continues to contribute to the development of innovative treatments and clinical best practices, with a lasting impact on global and regional healthcare.

NOTABLE PUBLICATION

Laparoscopic excision of seminal vesicle cystadenoma 2019 (4)

Burns injury characteristics and outcomes at lautoka hospital, fiji 2024

Characteristics and Outcomes of Acute Appendicitis in Lautoka Aspen Hospital, Fiji: An Observational Retrospective Study (09/22–09/23) 2024

Primary Epithelioid Hemangioendothelioma of the Kidney Pelvis 2020

Khalid M Alkharfy| Herbal Medicine and Nutraceuticals | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Khalid M Alkharfy| Herbal Medicine and Nutraceuticals | Best Researcher Award

King Saud University, Saudi Arabia

Author Profile

Early Academic Pursuits 🎓

Prof. Dr. Khalid M. Alkharfy began his academic journey with an unwavering commitment to pharmaceutical sciences. Graduating with class honors from King Saud University in 1992 with a Bachelor of Pharmaceutical Sciences (B.Sc. Pharm), he established a solid foundation for his future contributions to the field. His academic excellence continued as he pursued a Doctor of Pharmacy (Pharm.D) at the University of Tennessee, USA, graduating in 1997 with class honors. During this period, Dr. Alkharfy honed his skills as a pharmacy intern at leading healthcare institutions in Memphis, Tennessee, including Veterans Affairs Medical Center, Regional Medical Center, and Baptist Memorial Hospital. This formative training emphasized his proficiency in adjusting and monitoring drug therapies, providing patient counseling, and collaborating with multidisciplinary medical teams.

Furthering his expertise, Dr. Alkharfy earned a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Pittsburgh in 2002. This significant achievement, recognized with distinction in clinical research, underscored his ability to conduct groundbreaking studies and set the stage for his impactful career in clinical and translational research.

Professional Endeavors and Leadership 🏢

Dr. Alkharfy’s professional journey is characterized by a series of prominent leadership roles, showcasing his scientific acumen and administrative capabilities. Starting as a Clinical Instructor at King Khalid University Hospital (1992-1994), he contributed to training pharmacy students while working with the nephrology medical team. His academic and research career blossomed further during his tenure as a Research Associate (1997-2002) at the University of Pittsburgh Medical Center, where he played a pivotal role in designing and conducting clinical trials, analyzing data, and disseminating findings through conferences and publications.

Returning to Saudi Arabia, Dr. Alkharfy joined King Saud University in 2002 as a Professor of Clinical and Translational Research in the Department of Clinical Pharmacy. In this capacity, he has led numerous initiatives, including the Translational and Drug Discovery Unit and the Biomarkers Research Program, focusing on metabolic disorders and diabetes. His leadership extended beyond academia as he served as Dean of the College of Pharmacy at Prince Sattam University (2013-2016) and as the Founding Dean of Almaarefa University’s College of Pharmacy (2011-2013).Additionally, Dr. Alkharfy took on national responsibilities as a Consultant for the Saudi Food and Drug Authority (SFDA), advising on regulatory frameworks and ensuring pharmaceutical standards. His global contributions include Visiting Scholar positions at renowned institutions such as Mayo Clinic (USA), the University of Hong Kong, and Charles University (Czech Republic).

Contributions and Research Focus 🔬

Dr. Alkharfy has made profound contributions to clinical and translational research, with a focus on metabolic disorders, diabetes, and drug discovery. As a leader in the Biomarkers Research Program, he has designed innovative studies to identify novel therapeutic targets and biomarkers for chronic diseases. His expertise has also extended to creating an ecosystem for R&D projects as Director of Riyadh Techno Valley, where he fostered collaborations between academia, industry, and government to advance Saudi Arabia’s science and technology infrastructure.Dr. Alkharfy has authored and co-authored over 260 scientific papers, abstracts, and publications, many of which have appeared in high-impact, peer-reviewed journals. His work demonstrates a commitment to advancing global health through robust research methodologies and interdisciplinary collaboration.

Accolades and Recognition 🏆

Over the years, Dr. Alkharfy’s accomplishments have garnered international recognition. As a Fulbright Scholar at Mayo Clinic (2019), he contributed to advanced clinical research in diabetes and pharmacotherapy. His expertise earned him invitations to prestigious visiting scholar positions at leading universities worldwide, including the University of Campinas (Brazil), International Islamic University Malaysia, and the University of Auckland (New Zealand).Dr. Alkharfy’s innovation is further evidenced by his four registered patents across Saudi Arabia, the USA, and Europe, reflecting his commitment to translating research into tangible solutions. His leadership as Dean and consultant roles have been instrumental in shaping pharmacy education and regulatory practices in Saudi Arabia.

Impact and Influence 🌍

Dr. Alkharfy’s work has had a lasting impact on both academia and public health policy. As a leader in clinical and translational research, his studies on diabetes and metabolic disorders have influenced treatment paradigms, while his patents have contributed to drug discovery and development. His mentorship of young scientists and pharmacy students has inspired a new generation of researchers and clinicians in Saudi Arabia and beyond.

Through his roles in national regulatory bodies and academic institutions, Dr. Alkharfy has played a critical part in strengthening the research infrastructure in Saudi Arabia, promoting innovation, and aligning the country’s scientific endeavors with international standards.

Legacy and Future Contributions 🌟

As Dr. Khalid M. Alkharfy continues his illustrious career, his legacy is firmly rooted in his dedication to research excellence, leadership, and education. His work has set a benchmark for integrating clinical and translational research with public health initiatives, fostering international collaborations, and nurturing talent in pharmaceutical sciences.

📖Notable Publications

Effect of physical activity and sun exposure on vitamin D status of Saudi children and adolescents
  • Authors : Abdulaziz Al-Othman, Sara Al-Musharaf, Nasser M Al-Daghri, Soundararajan Krishnaswamy, Deqa S Yusuf, Khalid M Alkharfy, Yousef Al-Saleh, Omar S Al-Attas, Majed S Alokail, Osama Moharram, Shaun Sabico, George P Chrousos
  • Journal: BMC pediatrics
  • Year: 2012
Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency
  • Authors : Nasser M Al-Daghri, Omar S Al-Attas, Khalid M Alkharfy, Nasiruddin Khan, Abdul Khader Mohammed, Benjamin Vinodson, Mohammed Ghouse Ahmed Ansari, Amal Alenad, Majed S Alokail
  • Journal: Gene
  • Year: 2014
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition
  • Authors : Mohammad Raish, Ajaz Ahmad, Mushtaq Ahmad Ansari, Khalid M Alkharfy, Fahad I Aljenoobi, Basit L Jan, Abdullah M Al-Mohizea, Altaf Khan, Naushad Ali
  • Journal: Biological Macromolecules
  • Year: 2018
Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects
  • Authors : Nasser M Al‐Daghri, Khalid M Alkharfy, Shakilur Rahman, Osama E Amer, Benjamin Vinodson, Shaun Sabico, Milan K Piya, Alison L Harte, Philip G McTernan, Majed S Alokail, George P Chrousos
  • Journal: European Journal of Clinical Investigation
  • Year: 2014
Application of Box–Behnken design for ultrasonic-assisted extraction of polysaccharides from Paeonia emodi
  • Authors : Ajaz Ahmad, Khalid M Alkharfy, Tanveer A Wani, Mohammad Raish Ansari; Muzaffar Iqbal; Ali N; Alkharfy KM et al.
  • Journal:biological macromolecules
  • Year: 2015

Ajaz Ahmad| Drug Discovery and Development | Best Researcher Award

Posted on by sciencefather

Prof. Ajaz Ahmad | Drug Delivery Systems| Best Researcher Award

 King Saud University, Saudi Arabia

Author Profile

🎓Early Academic Pursuits 

Professor Ajaz Ahmad began his distinguished academic journey at the prestigious Hamdard University in New Delhi, India. He earned a Bachelor of Pharmacy (B.Pharm) in 2005, where he demonstrated an early inclination toward pharmaceutical sciences. Continuing his education at the same institution, he completed a Master of Pharmacy (M.Pharm) in 2007, refining his focus on drug delivery and molecular pharmacology. Driven by a passion for research, he pursued a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences, which he completed in 2011. His doctoral research laid the foundation for his expertise in drug discovery, pharmacokinetics, and the molecular mechanisms underpinning drug actions.

💼Professional Endeavors 

King Saud University, Saudi Arabia
Prof. Ahmad joined the College of Pharmacy at King Saud University in 2011 as an Assistant Professor in Clinical Pharmacy. Over the next decade, his contributions to research and teaching led to successive promotions—first as an Associate Professor in 2017 and then to his current role as Professor in Clinical Pharmacy in January 2024. At King Saud University, Prof. Ahmad’s role encompasses teaching advanced courses, mentoring postgraduate students, and conducting cutting-edge research in pharmacology and drug development.International Collaborations
Since 2015, Prof. Ahmad has served as a research collaborator with the Mayo Clinic, USA, a testament to his global reputation in pharmaceutical sciences. In 2013, he was appointed an Honorary Research Associate at the University of Hong Kong, further broadening his academic and professional network.Patents and Industry EngagementProf. Ahmad holds a U.S. patent (US20170231925A1) for treating neurovascular complications of diabetes mellitus. This innovation highlights his commitment to bridging the gap between research and practical healthcare applications.

🔬Contributions and Research Focus 

Prof. Ahmad’s research covers a broad spectrum of topics in pharmaceutical sciences, with particular focus areas including:Preclinical Drug Development: He has explored novel therapeutic agents, focusing on their efficacy, safety, and molecular mechanisms.Pharmacokinetics and Drug Metabolism: His work delves into the ADME (absorption, distribution, metabolism, and excretion) properties of drugs, optimizing formulations and dosing regimens.Bioanalytical Method Development: Prof. Ahmad designs and validates analytical methods for drug quantification, ensuring reproducibility and precision.Animal Models for Disease Research: He conducts in vivo studies simulating human diseases like cancer, diabetes, and cardiovascular disorders, with a focus on ethical handling and translational applications.Sepsis Research: Investigating biomarkers for early diagnosis and developing therapeutic strategies to combat sepsis.Vascular Pharmacology: Using myography techniques, he explores interventions for vascular diseases and evaluates novel therapeutic targets.

📖Notable Publications

Molecular insights into anti-Protozoal action of natural compounds against
  • Authors : Raish M; Ahmad A; MOHD SHAHNAWAZ KHAN; Kalam MA
  • Journal: biomolecular structure & dynamics
  • Year: 2023
A BOX-BEHNKEN DESIGN FOR OPTIMIZATION OF ULTRASOUND-ASSISTED EXTRACTION OF SINAPIC ACID FROM FRAGARIA ANANASSA
  • Authors : Mudassar Shahid; Ahmad A; Raish M; Bin Jardan YA; Alkharfy KM; Ahad A; Abul Kalam M; Ahmad Ansari M; Iqbal M; Ali N et al.
  • Journal: Pharmaceutical Society
  • Year: 2023
Sinapic acid alleviates 5-fluorouracil-induced nephrotoxicity in rats via Nrf2/HO-1 signalling.
  • Authors : Ahmad Ansari M; Shahid M; Ahmad SF; Ahmad A; Alanazi A; Malik A; Bin Jardan YA; Attia SM; Bakheet SA; Raish M
  • Journal: Pharmaceutical Sciences
  • Year: 2023
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
  • Authors : Zhang, M., Si, S.J., Dai, W.J., … Jin, F., Jiang, L.Q.
  • Journal: Pharmaceutical Society
  • Year: 2023
Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism.
  • Authors : Mohammad raish; Ahmad A; Mudassar Shahid; Yousef A Bin Jardan; Abdul Ahad; Dr Mohd Abul Kalam; Mushtaq Ahmad Ansari; Muzaffar Iqbal; Ali N; Alkharfy KM et al.
  • Journal:Molecules
  • Year: 2023

Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Xuzhou Medical University, China

Author Profile

🎓Early Academic Pursuits 

Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.

🌟Professional Endeavors 

Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.

He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.

🔬Contributions and Research Focus 

Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.

🏆Accolades and Recognition 

Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.

🌏Impact and Influence 

Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.

🌟Legacy and Future Contributions 

Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.

🌟Final Thoughts 

With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.

📖Notable Publications

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
  • Authors : Li, H., Liu, S., Dai, W., … Jin, F., Jiang, L.
  • Journal: Controlled Release
  • Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
  • Authors : Wang, Y., Wei, H., Song, Z., … Shu, Q., Xie, Y.
  • Journal: Ginseng Research
  • Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy

Ms. Frezer Kedir|Personalized Medicine|Women Researcher Award

Posted on by sciencefather

Ms. Frezer Kedir-Personalized Medicine-Women Researcher Award

Ms. Frezer Kedir at Institute of Health, Jimma University, Ethiopia

Author Profile

Early Academic Pursuits 🎓

Frezer Kedir Menu’s academic journey began with a strong foundation in primary education at Ingibi Elementary School and Ras Tesema Nado Elementary School. She demonstrated early promise, which propelled her to pursue her secondary education at Bedele Secondary School, completing it with distinction.

Frezer’s higher education commenced at KE-MED Medical College, where she acquired foundational medical knowledge between 1998 and 2001. Building on her passion for healthcare and academic excellence, she enrolled at Jimma University, earning a Bachelor of Science (BSc) degree in 2016. Driven by her unwavering commitment to advancing her knowledge and skills, she pursued a Master’s degree in Adult Health Nursing at the same university, completing it in 2024 with a commendable GPA of 3.64.

Professional Endeavors 💼

Frezer has accumulated over 12 years of hands-on experience in clinical healthcare, showcasing her dedication to patient care and medical excellence. She is currently serving as a Program Facilitator, a role that involves designing, implementing, and overseeing healthcare programs to ensure maximum impact. Her work reflects a deep understanding of clinical protocols and the ability to address complex health challenges in diverse settings.

Her career is not only defined by her clinical acumen but also by her commitment to fostering positive patient outcomes and empowering healthcare teams. Frezer’s experience in facilitating programs underscores her strong leadership capabilities and ability to drive organizational objectives effectively.

Contributions and Research Focus 🧪

Frezer’s research contributions highlight her dedication to addressing critical healthcare issues in Ethiopia. Her work spans a range of topics that directly impact patient care and public health, including:

  1. Dietary Knowledge and Its Associated Factors Among Diabetic Patients (2016):
    A study aimed at understanding dietary knowledge among diabetic patients at Jimma Medical Center, emphasizing the importance of nutrition in managing diabetes.
  2. Unmet Supportive Care Needs Among Cancer Patients (2023):
    This research explored the gaps in supportive care for cancer patients, providing insights into improving palliative care and patient support systems.
  3. Patient Engagement in Healthcare Decision-Making (2023):
    A project examining how patients with chronic non-communicable diseases in Southern Ethiopia engage in healthcare decisions, highlighting the significance of shared decision-making.
  4. Patient Autonomy in Managing Brachial Asthma (2024):
    This study focused on promoting patient autonomy and self-management in asthma care, offering strategies for better healthcare delivery in Southern Ethiopia.

Accolades and Recognition 🏆

Frezer’s work has earned her several certifications and accolades, which attest to her professional commitment and continuous growth. Notable achievements include:

  • Leadership Training Certificate: Demonstrating her ability to lead and train healthcare teams effectively.
  • PMTCT Training: Equipping her with essential skills to prevent mother-to-child transmission of diseases.
  • CISCO Certification: Enhancing her technical competencies in basic computer skills.
  • Operational Smile Training: Recognizing her contribution to healthcare training programs.
  • Developmental Team Training Certificate: Reflecting her focus on team-building and operational efficiency.

Impact and Influence 🌍

Frezer’s contributions extend beyond research and clinical work. Her role as a program facilitator allows her to influence healthcare delivery systems, ensuring they are inclusive and patient-centered. Through her research, she has shed light on critical healthcare gaps, prompting improvements in dietary education, supportive care, patient autonomy, and engagement in decision-making processes.

Legacy and Future Contributions 🌟

Frezer’s dedication to healthcare is creating a legacy of improved patient outcomes and enhanced healthcare systems in Ethiopia. Her research continues to inspire evidence-based practices, and her leadership in program facilitation fosters a culture of excellence within her teams.

In the future, Frezer aims to expand her impact by contributing to national healthcare policies, mentoring young professionals, and advocating for research-driven solutions to pressing healthcare challenges. She envisions a healthcare system that is both accessible and equitable, ensuring that every patient receives the care they deserve.

Notable Publications

Engagement in healthcare decision-making and associated factors among patients with chronic non-communicable diseases in Southwest Ethiopia

  • Authors   : Abdulwehab, S., Belay, Y., Kedir, F., Yimam, E., Belay, A.
  • Year         :2024

Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors,

      • Authors   : Abdulwehab, S., Kedir, F.
      • Year         :2024